Home > Clinical Trials
Check All Search

Saved trials

Terminated
NCT04209725
A Study of CPX-351 (Vyxeos™) With Quizartinib for the Treatment of FLT3-ITD Mutation-Positive Acute Myeloid Leukemia
1 Enrollment(s)
5 Study location(s)
Interventional (Phase II)
Leukemia, Myeloid, Acute
Completed
NCT02944019
Edoxaban Treatment in Routine Clinical Practice for Patients With Non Valvular Atrial Fibrillation
13,980 Enrollment(s)
724 Study location(s)
Observational
Atrial Fibrillation
Completed
NCT05022563
Treatment Patterns and Bleeding Risk of Anticoagulants in Patients With Venous Thromboembolism in Korea
100,000 Enrollment(s)
2 Study location(s)
Observational
Venous Thromboembolism
Withdrawn
NCT04676243
Daunorubicin or Idarubicin With Cytarabine Plus Quizartinib vs Physician's Choice in Newly Diagnosed FLT3-ITD+ AML
0 Enrollment(s)
0 Study location(s)
Interventional (Phase III)
Acute Myeloid Leukemia
Completed
NCT04425902
Evaluation of Pharmacokinetic Interaction Between GSK3640254 and Caffeine, Metoprolol, Montelukast, Flurbiprofen, Omeprazole, Midazolam, Digoxin, and Pravastatin in Healthy Adults
20 Enrollment(s)
1 Study location(s)
Interventional (Phase I)
HIV Infections
Terminated
NCT03552029
Milademetan Plus Quizartinib Combination Study in FLT3-ITD Mutant Acute Myeloid Leukemia (AML)
10 Enrollment(s)
8 Study location(s)
Interventional (Phase I)
Acute Myeloid Leukemia
Recruiting
NCT04542408
Hamburg Edoxaban for Anticoagulation in COVID-19 Study
172 Enrollment(s)
10 Study location(s)
Interventional (Phase III)
Covid19
Recruiting
NCT05066789
CHoice of Optimal Anti-Thrombotic Strategy in Patients Undergoing Implantation of Coronary Drug-Eluting Stents 4
4,000 Enrollment(s)
1 Study location(s)
Interventional (Phase IV)
Coronary Artery Disease